Finance Act 2022 – VAT Notes for Guidance

Revenue eBrief No. 214/22

VAT Notes for Guidance

Finance Act 2022 – VAT Notes for Guidance

Value-Added Tax Notes for Guidance – Finance Act 2022 – are now available on the Revenue website.

VAT Notes for Guidance Finance Act 2022

EXTRACT:

  1. Amendment of section 46 of the Value-Added Tax Consolidation
    Act 2010 (rates of tax)
    Summary
    This section amends section 46 of the Value-Added Tax Consolidation Act 2010 to provide that the temporary VAT rate of 9% continues to apply to supplies of gas and electricity up until 28 February 2023.
  1. Amendment of section 65 of the Value-Added Tax
    Consolidation Act 2010 (Registration)
    Summary
    This section amends section 65(3), as well as making consequential changes to sections 91C(2), 91E(2) and 91K(2) of the Value-Added Tax Consolidation Act 2010. A new requirement for VAT-registered traders who commence cross-border trade within the EU has been introduced. Traders that operate under a domestic VAT registration number are required to inform Revenue when they commence intra-Community trade to allow their registration status to be updated.
  1. Amendment of paragraph 2 of Schedule 1 to the Value-Added
    Tax Consolidation Act 2010 (medical and related services)
    Summary
    This section amends paragraph 2(3) of Schedule 1 of the Value-Added Tax Consolidation Act 2010 to clarify what medical professionals come within the scope of this exemption.
    Details
    This amendment clarifies that the exemption from VAT is limited to the provision of medical care services by medical and healthcare professionals who are registered or enrolled in a statutory register in the State.
  1. Amendment of Schedule 2 and Schedule 3 to the Value-Added Tax
    Consolidation Act 2010 (zero-rated goods and services)
    Summary
    This section amends Schedule 2 and 3 to the Value-Added Tax Consolidation Act 2010 to provide for the application of the zero-rate of VAT to the supply of:
  • newspapers, including e-newspapers,
  • non-oral hormone replacement therapy medicine and non-oral nicotine replacement therapy medicine,
  • automated external defibrillators, including parts or accessories suitable for use solely or principally with an automated external defibrillator, and
  • menstrual cups, menstrual pants and menstrual sponges